ES2054807T3 - Un procedimiento para preparar una suspension liquida de antibioticos para administracion oral. - Google Patents
Un procedimiento para preparar una suspension liquida de antibioticos para administracion oral.Info
- Publication number
- ES2054807T3 ES2054807T3 ES88305556T ES88305556T ES2054807T3 ES 2054807 T3 ES2054807 T3 ES 2054807T3 ES 88305556 T ES88305556 T ES 88305556T ES 88305556 T ES88305556 T ES 88305556T ES 2054807 T3 ES2054807 T3 ES 2054807T3
- Authority
- ES
- Spain
- Prior art keywords
- active ingredient
- oral administration
- liquid suspension
- antibiotics
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SUSPENSION LIQUIDA PARA ADMINISTRACION ORAL QUE COMPRENDE UN INGREDIENTE ACTIVO SUSPENDIDO EN UN VEHICULO COMESTIBLE NO ACUOSO, TAL COMO UN ACEITE EN LA QUE EL INGREDIENTE ACTIVO ESTA EN FORMA DE PARTICULAS DE LIBERACION CONTROLADA QUE CONTIENEN EL INGREDIENTE ACTIVO Y OPCIONALMENTE UN EXCIPIENTE EN MEZCLA INTIMA CON POR LO MENOS UN POLIMERO NO TOXICO, ESTANDO LAS PARTICULAS RECUBIERTAS DISTRIBUIDAS O ADSORBIDAS SOBRE DICHO POLIMERO Y TENIENDO LAS PARTICULAS UN TAMAÑO MEDIO EN LA GAMA DE 0,1 A 150 MICRAS Y UNA LIBERACION PREDETERMINADA DEL INGREDIENTE ACTIVO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE164587A IE59934B1 (en) | 1987-06-19 | 1987-06-19 | Liquid suspension for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2054807T3 true ES2054807T3 (es) | 1994-08-16 |
Family
ID=11030020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88305556T Expired - Lifetime ES2054807T3 (es) | 1987-06-19 | 1988-06-17 | Un procedimiento para preparar una suspension liquida de antibioticos para administracion oral. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5156842A (es) |
EP (1) | EP0295941B1 (es) |
JP (1) | JPS6416717A (es) |
AT (1) | ATE86851T1 (es) |
CA (1) | CA1314215C (es) |
DE (1) | DE3879286T2 (es) |
DK (1) | DK175812B1 (es) |
ES (1) | ES2054807T3 (es) |
IE (1) | IE59934B1 (es) |
PH (1) | PH24979A (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04506216A (ja) * | 1989-06-13 | 1992-10-29 | アボツト・ラボラトリーズ | 薬物送達用の油を主成分とした非水性液体懸濁液 |
US5496535A (en) * | 1991-04-12 | 1996-03-05 | Alliance Pharmaceutical Corp. | Fluorocarbon contrast media for use with MRI and radiographic imaging |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
US5665382A (en) * | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
US5997904A (en) * | 1993-02-22 | 1999-12-07 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US5650156A (en) * | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
US6528067B1 (en) | 1993-02-22 | 2003-03-04 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
CN1245156C (zh) * | 1993-02-22 | 2006-03-15 | 美国生物科学有限公司 | 用于体内传送生物制品的方法及用于该方法的组合物 |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
CA2189001A1 (en) * | 1994-04-26 | 1995-11-02 | Nobuhiro Narita | Medicinal composition as a remedy for nonsmall cell lung cancer |
US5484800A (en) * | 1994-08-30 | 1996-01-16 | American Home Products Corporation | Lipid-based liquid medicinal composition |
SI9400338A (en) * | 1994-08-31 | 1996-04-30 | Lek D D | Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules. |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5916566A (en) * | 1995-06-07 | 1999-06-29 | Avmax, Inc. | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
US5665386A (en) * | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US6180666B1 (en) | 1997-09-05 | 2001-01-30 | Anmax, Inc. | Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds |
US5962522A (en) * | 1997-09-05 | 1999-10-05 | Avmax, Inc. | Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds |
BR9705470A (pt) * | 1997-11-12 | 1999-07-06 | Ind Quimica E Farmaceutica Sch | Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6846495B2 (en) | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US7935362B2 (en) | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
AU3885201A (en) | 1999-09-20 | 2001-04-24 | Mastercare | Diet and weight control gum and sucker |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
US7115288B2 (en) | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6919370B2 (en) | 2000-11-28 | 2005-07-19 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
US20040092428A1 (en) * | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
US20040043073A1 (en) * | 2002-06-14 | 2004-03-04 | Chih-Ming Chen | Pharmaceutical compositions for drugs having pH-dependent solubility |
US20040202696A1 (en) * | 2003-04-14 | 2004-10-14 | Cts Chemical Industries Ltd. | Administration form for veterinary use |
GB0308732D0 (en) | 2003-04-15 | 2003-05-21 | Axcess Ltd | Absorption enhancers |
GB0308734D0 (en) | 2003-04-15 | 2003-05-21 | Axcess Ltd | Uptake of macromolecules |
PL1638529T3 (pl) * | 2003-06-16 | 2017-03-31 | Andrx Pharmaceuticals, Llc. | Kompozycja doustna o przedłużonym uwalnianiu |
WO2011107855A2 (en) | 2010-03-04 | 2011-09-09 | Torrent Pharmaceuticals Limited | Sustained release oral liquid suspension dosage form |
FR3000400B1 (fr) * | 2012-12-27 | 2019-06-21 | Virbac | Suspension huileuse de metronidazole |
US20170326161A1 (en) * | 2015-12-10 | 2017-11-16 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE567598A (es) * | ||||
JPS4971127A (es) * | 1972-11-18 | 1974-07-10 | ||
US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
US4181721A (en) * | 1975-10-27 | 1980-01-01 | Schering Aktiengesellschaft | Depot preparations in an oily, unsaturated solution for intramuscular injection |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
DE3309763A1 (de) * | 1983-03-18 | 1984-09-20 | Bayer Ag | Stabile aminoglykosid-penicillin-injektionsformulierungen |
JPS60193914A (ja) * | 1984-03-14 | 1985-10-02 | Kao Corp | 含粒油性薬剤組成物 |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
FR2576213B1 (fr) * | 1985-01-21 | 1989-02-24 | Cortial | Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee |
SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
-
1987
- 1987-06-19 IE IE164587A patent/IE59934B1/en not_active IP Right Cessation
-
1988
- 1988-06-09 PH PH37037A patent/PH24979A/en unknown
- 1988-06-17 JP JP63149921A patent/JPS6416717A/ja active Pending
- 1988-06-17 EP EP88305556A patent/EP0295941B1/en not_active Expired - Lifetime
- 1988-06-17 DE DE8888305556T patent/DE3879286T2/de not_active Expired - Lifetime
- 1988-06-17 CA CA000569795A patent/CA1314215C/en not_active Expired - Lifetime
- 1988-06-17 ES ES88305556T patent/ES2054807T3/es not_active Expired - Lifetime
- 1988-06-17 DK DK198803336A patent/DK175812B1/da not_active IP Right Cessation
- 1988-06-17 AT AT88305556T patent/ATE86851T1/de not_active IP Right Cessation
-
1991
- 1991-09-27 US US07/769,160 patent/US5156842A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IE871645L (en) | 1988-12-19 |
IE59934B1 (en) | 1994-05-04 |
ATE86851T1 (de) | 1993-04-15 |
PH24979A (en) | 1990-12-26 |
JPS6416717A (en) | 1989-01-20 |
CA1314215C (en) | 1993-03-09 |
DK333688D0 (da) | 1988-06-17 |
DE3879286T2 (de) | 1993-09-23 |
EP0295941B1 (en) | 1993-03-17 |
DE3879286D1 (de) | 1993-04-22 |
DK175812B1 (da) | 2005-03-07 |
EP0295941A3 (en) | 1989-03-15 |
EP0295941A2 (en) | 1988-12-21 |
DK333688A (da) | 1988-12-20 |
US5156842A (en) | 1992-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2054807T3 (es) | Un procedimiento para preparar una suspension liquida de antibioticos para administracion oral. | |
HUT50050A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions | |
NO931710D0 (no) | Fremgangsmaate for fremstilling av en stabil ikkeagglomerende, vandig suspensjon av et oljeopploeselig, polymert, friksjonsreduserende middel | |
AU4739790A (en) | Process for micro-encapsulation | |
AU2447288A (en) | Drug carriers | |
AU2002892A (en) | Porous inorganic ultrasound contrast agents | |
AU5478386A (en) | Drug carrier and pharmaceutical preparation comprising the same | |
PT654263E (pt) | Metodo para a preparacao de uma composicao de libertyacao prolongada | |
AU588946B2 (en) | Time duration indicator systems, and also products containing such indicator systems having a limited duration of use or life | |
FI971880A0 (fi) | Helposti sulavan kantajan sisältävä farmaseuttinen koostumus ja menetelmä sen valmistamiseksi | |
NZ219140A (en) | Sustained release capsule containing active adsorbed on polymer | |
AU4959485A (en) | Controlled release nifedipine preparation | |
PL308838A1 (en) | Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations | |
EP0017176A3 (en) | Process for immobilizing enzymatically active preparations | |
IL80182A (en) | Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance | |
PT83009B (pt) | Processo para a preparacao de composicoes farmaceuticas com libertacao controlada e prolongada da substancia activa | |
AU5140490A (en) | Use of mixed micelles | |
AU6322686A (en) | Pharmaceutical formulations with controlled release of the active substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 295941 Country of ref document: ES |